Latest Insider Transactions at Cullinan Oncology, Inc. (CGEM)
This section provides a real-time view of insider transactions for Cullinan Oncology, Inc. (CGEM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Cullinan Oncology, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Cullinan Oncology, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 12
2021
|
Ubs Oncology Impact Fund L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
7,613,887
+31.4%
|
-
|
|
Jan 07
2021
|
Ansbert Gadicke Director |
BUY
Other acquisition or disposition
|
Direct |
281,268
+50.0%
|
-
|